All Q2 FY27 results →
CA

Chemfab Alkalis Ltd

Q2 FY27Chemicals & Petrochemicals

Chemfab Alkalis Q2 Results 2026 (FY27): Revenue ₹75.61 Cr, PAT ₹7.51 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹309
Market cap₹444 Cr
Updated29 Oct 2026
Read3 min read

Chemfab Alkalis Ltd Q2 FY27 key numbers

Revenue
Q2 FY27 Revenue from Operations (Consolidated): ₹75.61 crore.

As stated in Chemfab Alkalis Ltd's Q2 FY27 investor presentation · published 29 Oct 2026. Reported figures, not investment advice.

Based on Chemfab Alkalis Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY27 Revenue from Operations (Consolidated): ₹75.61 crore Q2 FY27 EBITDA (Operational): ₹7.04 crore, up 28.94% YoY (Q2 FY26: ₹5.46 crore)

From Chemfab Alkalis Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.

How did Chemfab Alkalis' revenue grow in the September 2026 quarter?

- **Q2 FY27 Revenue from Operations (Consolidated):** ₹75.61 crore - YoY change: -1.24% (compared to Q2 FY26 revenue of ₹76.56 crore) - **Chemical Segment Revenue Q2 FY27:** ₹69.22 crore - YoY change: +38.94% (vs. ₹49.82 crore in Q2 FY26) - **OPVC Pipes Segment Revenue Q2 FY27:** ₹6.39 crore - YoY change: -76.10% (vs. ₹26.74 crore in Q2 FY26) **Outlook:** - Chemical business expects improved financial performance in H2 FY27 due to stabilized ECU realizations and efficiency gains.

2 more points from Chemfab Alkalis Ltd's call on revenue

Create a free account to keep reading this call

What happened to Chemfab Alkalis' margins in Q2 FY27?

See what Chemfab Alkalis Ltd said on profitability & margins — free account, 30 seconds.

What capex is Chemfab Alkalis planning?

  • Chlor-Alkali Business:
  • ₹56 crore invested in technology modernization to replace 1994 electrolyser tech; completed shutdown and fully operational by Q3 FY26.
  • ₹15 crore invested in hybrid power project under SPV; supply started Q1 FY27.
  • OPVC Pipes Business:
  • Capacity expansion from 14,000 TPA (FY25) to 20,000 TPA (FY26) with new lines in Sri City.
  • Operational Lines and Capex at Sri City:
  • Line 5 (Q2 FY26): +3,000 TPA, ₹27 crore capex.
  • Line 6 (Q3 FY26): +3,000 TPA, ₹28 crore capex.
  • Line 7 (Q4 FY27): +3,000 TPA, ₹30 crore capex planned.

2 more points from Chemfab Alkalis Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Chemfab Alkalis raising money or cutting debt?

See what Chemfab Alkalis Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Chemfab Alkalis' order book?

See what Chemfab Alkalis Ltd said on order book & pipeline — free account, 30 seconds.

Chemfab Alkalis Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹76 Cr, net loss ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemfab Alkalis Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemfab Alkalis Ltd Q2 FY27 results?

Q2 FY27 Revenue from Operations (Consolidated): ₹75.61 crore Q2 FY27 EBITDA (Operational): ₹7.04 crore, up 28.94% YoY (Q2 FY26: ₹5.46 crore)

What is Chemfab Alkalis Ltd share price analysis?

Chemfab Alkalis Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹444 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemfab Alkalis Ltd planning capital expenditure?

Chlor-Alkali Business: - ₹56 crore invested in technology modernization to replace 1994 electrolyser tech; completed shutdown and fully operational by Q3 FY26.

Keep Chemfab Alkalis Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.